Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Clin Oncol. Aug 10, 2014; 5(3): 323-334
Published online Aug 10, 2014. doi: 10.5306/wjco.v5.i3.323
Table 1 mRNA half-life modulators in breast cancer
mRNA half-life modulatorsMain targetPrognostic factorRef.
RBPs
TTPGM-CSF, cox2, VEGF, IL8, HIF1a, TNF-αYesGriseri and Pagès
HuRGM-CSF, cox2, VEGF, IL8, TGFB, TNF-αYesGriseri and Pagès
microRNA
miR125a, miR125bHER2, HER3, cRAF, HuRPossible[115-117]
miR206ERUnknown[118,119]
miR200Zfhx1bYes[120,137,138]
miR506cdh1Unknown[121]
miR34Fra1Unknown[122]
miR31Fzd3, ITGA5, MMP16, RDX, RhoAUnknown[123]
miR203BIRC5, LASP1Unknown[124]
miR21PDC4Unknown[125]
miR26bPTGS2Unknown[126]
miR124cd151Unknown[127]
miR29aTTPUnknown[128]
miR3134SOX9, VEGFA, EGFRUnknown[130]
miR125HuRUnknown[115]
lncRNA
aHIFPossible[132,133]